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results in only 44%, 40%, 31%, 28% and 20% of the variance of 
tumor motion being explained by local rectum motion for 
respectively ProximateRectums of 1, 3, 5, 7 and 10 mm. 
 
Conclusion: Even when the rectal motion surrogate is 
defined within 1 mm of the tumor, tracking this part of the 
rectal wall will not result in an accurate tumor positions 
since only 44% of the variance in tumor motion is explained 
by tracking the rectal wall. The lack of anatomical landmarks 
prevents finding the true rectum deformation and thus an 
accurate tumor position. Especially for motion in cranial-
caudal direction, there is poor correlation between tumor 
and local rectal motion. Therefore, anatomical landmarks are 
needed for positioning the tumor e.g. direct imaging of the 
tumor using MRI or indirect imaging of the tumor using 
implanted markers. 
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Purpose or Objective: In cervical cancer, adaptive radiation 
therapy (ART) can be applied to compensate for interfraction 
target motion. However, organs at risk (OAR) still receive 
substantial dose when photon-based ART is applied. Adaptive 
proton therapy (APT) holds the promise to further limit OAR 
dose while maintaining adequate target coverage. Our aim 
was to investigate the potential dosimetric advantages of 
image-guided APT (IGAPT) compared with photon-based 
image-guided ART (IGART). 
 
Material and Methods: Twelve cervical cancer patients 
treated with photon therapy were included in this 
retrospective study. Besides the clinically acquired full 
bladder planning CT, additional empty bladder planning CT 
and weekly repeat CTs were acquired for study purposes. 
Planning CTs were registered based on bony anatomy and 
multiple interpolated cervix-uterus structures were derived 
using a point-based non-rigid registration method. For each 
interpolated structure, a photon (VMAT) and a proton (IMPT) 
plan was created to build patient-specific plan libraries. All 
plans were robustly optimized with a prescribed physical CTV 
dose of 46 Gy-equivalent (GyE) (23 x 2 GyE) for pelvic 
irradiation or 50.4 GyE (28 x 1.8 GyE) for para-aortic 
irradiation. For each patient, repeat CTs were registered to 
the full bladder planning CT based on bony anatomy and 
IGART and IGAPT treatments were simulated by selecting 
library plans and recalculating the dose. For each simulated 
fraction, CTV coverage (V95% > 98%) was assessed and 
differences in Dmean and D2cc fraction dose and fractionated 
substitutes of V15Gy, V30Gy and V45Gy parameters (i.e. dose 
levels divided by the number of fractions) for bladder, bowel 
and rectum were evaluated and tested for significance 
(Wilcoxon signed-rank test). Also, fraction dose distributions 
were accumulated and differences in the overall rectum 
toxicity related DVH parameter (V30Gy) and normal tissue 
complication probability (NTCP) for grade 2 acute 
gastrointestinal toxicity were determined. 
 
Results: In 6 fractions (10.7%), the cervix-uterus structure 
deviated substantially from the pre-treatment derived 
structures. Adequate CTV coverage was obtained in 92% (96%) 
of the remaining fractions for IGAPT (IGART) which resulted 
in adequate CTV coverage on average per patient. All DVH 
parameters for bladder, bowel and rectum, except for the 
fractionated substitute of rectum V45Gy, were improved 
using IGAPT (Figure). Also, the mean dose to bowel, bladder 
and rectum was reduced significantly (p<0.01). Compared to 
IGART, IGAPT indicated a mean reduction of 7% for rectum 
V30Gy and a mean decrease from 0.33 to 0.18 in bowel 
NTCP. 
 
 
 
Conclusion: This study demonstrates the feasibility of IGAPT 
in cervical cancer using a plan library based adaptive strategy 
to compensate for interfraction target motion. Compared to 
photon-based IGART, IGAPT maintains adequate target 
coverage while a significant dose reduction in bladder, bowel 
and rectum can be achieved. 
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